Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.36B | $15.83B | $14.28B | $13.40B | $12.64B | $11.56B | $11.38B | $10.77B | $10.41B | $9.77B | $9.04B | $8.21B | $7.37B | $6.96B | $6.76B | $4.90B | — | — |
| Operating expenses | $15.37B | $14.15B | $13.11B | $12.40B | $11.28B | $10.20B | $10.16B | $9.60B | $9.13B | $8.48B | $7.78B | $7.14B | $6.35B | $6.02B | $5.86B | $4.39B | $4.68B | $4.61B |
| Operating income | $1.99B | $1.68B | $1.18B | $1.00B | $1.36B | $1.36B | $1.22B | $1.18B | $1.28B | $1.28B | $1.26B | $1.06B | $1.02B | $942.6M | $897.1M | $505.7M | $520.5M | $410.2M |
| EBITDAderived | $2.61B | $2.27B | $1.74B | $1.59B | $1.90B | $1.87B | $1.71B | $1.63B | $1.73B | $1.70B | $1.66B | $1.44B | $1.35B | $1.25B | $1.19B | $729.7M | $725.2M | $606.0M |
| Net income | $1.49B | $1.14B | $717.8M | $675.6M | $991.6M | $944.0M | $814.9M | $779.7M | $752.3M | $702.4M | $680.5M | $545.3M | $510.7M | $443.4M | $398.2M | $230.2M | $260.4M | $199.4M |
| Basic EPSper diluted share | $23.42 | $17.16 | $10.35 | $9.23 | $11.99 | $11.06 | $9.16 | $8.35 | $7.86 | $7.22 | $6.89 | $5.52 | $5.21 | $4.57 | $4.09 | $2.37 | $2.65 | $1.96 |
| Diluted EPSper diluted share | $23.10 | $16.82 | $10.23 | $9.14 | $11.82 | $10.99 | $9.13 | $8.31 | $7.81 | $7.14 | $6.76 | $5.42 | $5.14 | $4.53 | $4.04 | $2.34 | $2.64 | $1.96 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 13, 2026Form 4 | SUSSMAN ELLIOT J MD MBADirector | SellClass B Common Stock | 356 | $193.37 | $68.8K | 6.1K |
| Mar 11, 2026Form 4 | SUSSMAN ELLIOT J MD MBADirector | SellClass B Common Stock | 318 | $186.35 | $59.3K | 6.1K |
| Nov 11, 2025Form 4 | Nimetz Warren J.Director | SellClass B Common Stock | 142 | $223.96 | $31.8K | 8.5K |
| Nov 11, 2025Form 4 | Nimetz Warren J.Director | SellClass B Common Stock | 3.7K | $223.28 | $820.6K | 8.6K |
| Oct 29, 2025Form 4 | SUSSMAN ELLIOT J MD MBADirector | SellClass B Common Stock | 965 | $225.70 | $217.8K | 6.1K |